Patients | Histological subtype | MAGE-A1(77B mAb) | Multi-MAGE-A(57B mAb) | NY-ESO-1(D8.38 mAb) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
 |  | % of positive tumor cells | Staining score | Staining intensity | % of positive tumor cells | Staining score | Staining intensity | % of positive tumor cells | Staining score | Staining intensity |
1 | FL | 0 | 0 | 0 | 90 | 3 | 2 | 80 | 3 | 1 |
2 | SLL | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
3 | B-LBL | 0 | 0 | 0 | 100 | 3 | 1 | 0 | 0 | 0 |
4 | DLBCL | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 2 | 1 |
5 | DLBCL | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
6 | DLBCL | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
7 | DLBCL | 100 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
8 | DLBCL | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
9 | DLBCL | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
10 | DLBCL | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
11 | DLBCL | 80 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
12 | DLBCL | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 3 | 1 |
13 | DLBCL | 10 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
14 | DLBCL | 0 | 0 | 0 | 100 | 3 | 2 | 100 | 3 | 2 |
15 | DLBCL | 0 | 0 | 0 | 100 | 3 | 3 | 100 | 3 | 2 |
16 | DLBCL | 0 | 0 | 0 | 100 | 3 | 2 | 100 | 3 | 2 |
17 | DLBCL | 0 | 0 | 0 | 100 | 3 | 2 | 0 | 0 | 0 |
18 | DLBCL | 0 | 0 | 0 | 100 | 3 | 1 | 0 | 0 | 0 |
19 | DLBCL | 0 | 0 | 0 | 100 | 3 | 2 | 100 | 3 | 3 |
20 | DLBCL | 0 | 0 | 0 | 70 | 3 | 1 | 90 | 3 | 1 |
21 | DLBCL | 0 | 0 | 0 | 100 | 3 | 2 | 100 | 3 | 2 |
22 | DLBCL | 0 | 0 | 0 | 100 | 3 | 3 | 0 | 0 | 0 |
23 | DLBCL | 0 | 0 | 0 | 100 | 3 | 2 | 100 | 3 | 1 |
24 | DLBCL | 0 | 0 | 0 | 90 | 3 | 1 | 0 | 0 | 0 |
25 | DLBCL | 0 | 0 | 0 | 80 | 3 | 2 | 0 | 0 | 0 |
26 | DLBCL | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
27 | DLBCL | 0 | 0 | 0 | 100 | 3 | 1 | 0 | 0 | 0 |